Withanamides in Withania somnifera fruit protect PC-12 cells from β-amyloid responsible for Alzheimer's disease

Phytotherapy Research

Volumn 24, Issue 6, 2010, Pages 859-863

  Jayaprakasam, Bolleddula ^a   Padmanabhan, Kaillathe ^b   Nair, Muraleedharan G ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Michigan State University   (United States)

Author keywords

amyloid peptide; Aswagandha; Lipid peroxidation; Molecular models; Neuronal cells

Indexed keywords

AMYLOID BETA PROTEIN; ANTIOXIDANT; UNCLASSIFIED DRUG; WITHANAMIDE A; WITHANAMIDE B;

ALZHEIMER DISEASE; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DAMAGE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; FIBER; FRUIT; IN VIVO STUDY; LIPID PEROXIDATION; MOLECULAR MODEL; NERVE CELL; NONHUMAN; PROTEIN BINDING; PROTEIN MOTIF; RAT; WITHANIA SOMNIFERA;

ALZHEIMER DISEASE; AMIDES; AMYLOID BETA-PROTEIN; ANIMALS; CELL SURVIVAL; DISACCHARIDES; FRUIT; INDOLES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PC12 CELLS; PEPTIDE FRAGMENTS; RATS; WITHANIA;

RATTUS; WITHANIA SOMNIFERA;

EID: 77953250722     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3033     Document Type: Article

References (21)

1. Anekonda TS. 2006. Resveratrol - A boon for treating Alzheimer's disease? Brain Res Rev 52: 316-326.
2. Cummings JL, Vinters HV, Cole GM, Khachaturian ZS. 1998. Alzheimer's disease: Etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 51: S2-S17. (Pubitemid 28345337)
3. Dai Q, Borenstein AR, Wu Y, Jackson JC, Larson EB. 2006. Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am J Med 119: 751-759.
4. Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ. 2007. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102: 1095-1014.
5. Hardy JA, Higgins GA. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184-185.
6. Hebert LE, Scherr PA, Bienias JL, Bennet DA, Evans DA. 2003. Alzheimer disease in the US population. Prevalence estimates using the 2000 census. Arch Neurol 60: 1119-1112.
7. Jayaprakasam B, Nair MG. 2003a. Cyclooxygenase-2 inhibitory withanolides from Withania somnifera leaves. Tetrahedron 59: 841-849. (Pubitemid 36126677)
8. Jayaprakasam B, Zhang, Y, Seeram NP, Nair MG. 2003b. Growth inhibition of human tumor cell lines by withanolides from Withania somnifer. Life Sci 74: 125-134.
9. Jayaprakasam B, Strasburg GA, Nair MG. 2004. Potent lipid peroxidation inhibitors from Withania somnifera. Tetrahedron 60: 3109-3121.
10. Kim DHSL, Park S-Y, Kim J-Y. 2001. Curcuminoids from Curcuma longa L (Zingiberaceae) that protects PC-12 rat peochromocytoma and normal umbilical vein endothelial cells from βA (1-42) insult. Neurosci Let 303: 57-61.
11. Lührs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Döbeli H, Schubert D, Riek R. 2005. 3D structure of Alzheimer's amyloid-β 1-42 fibrils. Proc Nat Acad Sci 102: 17342-17347.
12. Maria M, Thimmappa SA, Edward H, Byung SP, Joseph Q, Reddy PH. 2006. Mitochondria are a direct site of Aß accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mole Genet 15: 1437-1449.
13. Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. 2004. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142: 37-46.
14. Nunan J, Small DH. 2000. Regulation of APP cleavage by α, β, and γ- secretases. FEBS Lett 483: 6-10.
15. Ochiai T, Ohno S, Soeda S, Tanaka H, Shoyama Y, Shimeno H. 2004. Crocin prevents the death of rat pheochromycroma (PC-12) cells by its antioxidant effects stronger than those of α-tocopherol. Neurosci Lett 362: 61-64.
16. Orgogozo JM, Dartigues JF, Lafont S, Letenneur L, Commenges D, Salamon R, Renaud S, Breteler MB. 1997. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) 153: 185-192. (Pubitemid 27262834)
17. Sadowski J, Gasteiger J. 1993. From atoms and bonds to three-dimensional atomic coordinates: automatic model builders. Chem Reviews 93: 2567-2581.
18. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. 1997. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. New Engl J Med 336: 1216-1222.
19. Smith PF, Maclennan K, Darlington CL. 1996. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). J Ethnopharmacol 50: 131-139.
20. Thakur RS, Puri HS, Husain A. 1989. Major medicinal plants of India. CIMAP: Lucknow, India; 531-534.
21. Zhu XW, Raina AK, Lee HG, Casadesus G, Smith MK, Perry G. 2004. Oxidative stress signalling in Alzheimer's disease. Brain Res 1000: 32-39. (Pubitemid 38446487)